HOME

TECHS

View more

NEWS

View more

EVENTS

View more

MISSION

Using state of the art technologies, we aim at manufacturing kits for the analysis and editing of therapeutically relevant antibodies such as monoclonal antibodies effective against immunology disorders or oncology.
Our kits for antibody genome sequencing and editing are based on the NGS method (next generation sequencing) and the CRISPR-Cas9 method (clustered regularly interspaced short palindromic repeats-associated protein 9).

LATEST NEWS

05.03.2022

Bitcoin World Forum

The event, which will be held at the Palazzo dei Congressi in Lugano from 26 to 28 October 2022, will...

View more

04.03.2022

ICPPB

The 16th International Conference on Pharmacognosy and Pharmaceutical Biotechnology (ICPPB) will be held...

View more

03.03.2022

Lugano as an European centre of excellence for the adoption of blockchain technology

The City of Lugano and Tether Operations Limited, the company behind the blockchain-based platform that...

View more

Events

7

News

12

Online users

3

ALL OUR VIDEOS

View more

Partners

Swiss Hospitality Specialist
BKN Sagl
Swiss Biotech Association
Enogastro Info
DREAMagent

Newsletter subscription